828242-83-7Relevant articles and documents
Anti-inflammatory agents
-
Page/Page column 149, (2016/02/05)
Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.
Photoactivatable fluorescein derivatives caged with a (3-hydroxy-2- naphthalenyl)methyl group
Nekongo, Emmanuel E.,Popik, Vladimir V.
, p. 7665 - 7671 (2014/09/17)
The (3-hydroxy-2-naphthalenyl)methyl (NQMP) group represents an efficient photocage for fluorescein-based dyes. Thus, irradiation of the 6-NQMP ether of 2'-hydroxymethylfluorescein with low-intensity UVA light results in a 4-fold increase in emission inte
ARYLAMINE-SUBSTITUTED QUINAZOLINONE COMPOUNDS
-
Page 70, (2010/02/10)
Compounds represented by Formula (I) which are useful as are alpha-1A/B adrenoceptor antagonists, to methods of treating conditions associated with the activity of alpha-1A/B adrenoceptors, and to methods of making said compounds, wherein Ar, Z, R, R', R